Highlights from the latest pharmacogenomic genome-wide association studies

Pharmacogenomics. 2013 Mar;14(4):357-60. doi: 10.2217/pgs.13.17.
No abstract available

Publication types

  • Comment

MeSH terms

  • Animals
  • Antimetabolites, Antineoplastic / pharmacokinetics*
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Biomedical Research*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics*
  • Cell Cycle Proteins / genetics*
  • Chromosomes, Human, Pair 10*
  • DNA-Binding Proteins / genetics*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / genetics*
  • Drug Industry*
  • Exons*
  • Female
  • Genetic Loci*
  • Genetic Variation*
  • Genome-Wide Association Study*
  • Humans
  • Male
  • Metabolism / genetics*
  • Metformin / pharmacology*
  • Methotrexate / pharmacokinetics*
  • Neoplasm Proteins / genetics*
  • Organic Anion Transporters / genetics*
  • Polymorphism, Single Nucleotide*
  • Protein Serine-Threonine Kinases / genetics*
  • Tamoxifen / therapeutic use*
  • Tumor Suppressor Proteins / genetics*

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents, Hormonal
  • Cell Cycle Proteins
  • DNA-Binding Proteins
  • Neoplasm Proteins
  • Organic Anion Transporters
  • Tumor Suppressor Proteins
  • Tamoxifen
  • Metformin
  • Protein Serine-Threonine Kinases
  • Methotrexate